Navigation Links
Rash Due to Lung Cancer Drug May Be Linked to Better Survival
Date:12/20/2010

MONDAY, Dec. 20 (HealthDay News) -- Lung cancer patients who develop a rash after treatment with the drug cetuximab (Erbitux) have better outcomes, according to a new study.

German researchers compared hundreds of patients with non-small cell lung cancer who received chemotherapy plus cetuximab and hundreds of patients who received chemotherapy alone. About 70 percent of the patients who received the combination therapy developed an acne-like rash within the first three weeks of treatment.

Compared to other patients, those who developed the rash lived longer (15 months vs. 8.8 months), had better progression-free survival (5.4 months vs. 4.3 months) and had a higher response rate (44.8 percent vs. 32 percent), according to the report by Dr. Ulrich Gatzemeier, from Hospital Grosshansdorf in Germany, and colleagues.

The findings, published online Dec. 19 in The Lancet Oncology, suggest that the early appearance of a skin rash may help identify patients who would be most likely to respond to treatment with cetuximab and gain the greatest survival benefit, the researchers noted.

The study authors concluded that further clinical trials are needed "to verify this finding and assess it fully in the context of possible clinical application."

In a commentary accompanying the report, Dr. Francesco Perrone from the Istituto Nazionale Tumori in Naples, Italy, added: "The only way to verify the hypothesis that skin rash predicts the benefit of cetuximab is a randomized trial that compares interruption versus continuation of cetuximab in patients with skin rash after three weeks of treatment with cetuximab and chemotherapy."

The findings, Perrone continued, "must be validated prospectively before we consider the introduction of cetuximab into clinical practice for the treatment of patients with advanced non-small cell lung cancer."

More information

The American Cancer Society has more a
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rash Due to Lung Cancer Drug May Be Linked to Better Survival
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market ... 7.8% from 2014 to 2019. , The global digital PCR (dPCR) ... 7.8% from 2014 to 2019. Although the mature markets such as ... digital PCR (dPCR) and qPCR market the Asia-Pacific region is expected ... period. The growth of the digital PCR (dPCR) and qPCR market ...
(Date:3/5/2015)... 05, 2015 Risperdal lawsuits ( ... Pennsylvania mass tort litigation currently underway in the ... has begun hearing testimony in the proceeding’s second ... medication can cause gynecomastia, or male breast growth. ... was filed on behalf of a plaintiff who ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction Conference ... met today in Jackson, Mississippi to listen to keynote ... numerous respected speakers will be William S. Jacobs, ... pain medications have had in today’s opiate overdose and ... is hard to believe that much of the current ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Taking ... in Fort Worth, Texas April 9-11th is IDRevolution ... company providing personalized nutrition. IDLife offers a ... IDNutrition. This customized approach to vitamin supplementation ... begins with a free HIPAA compliant online assessment ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2
... explanations, study finds , TUESDAY, March 30 (HealthDay News) -- ... trials, most do not receive a clear explanation of their ... report suggests. , In the study, U.S. researchers interviewed 37 ... that more than half of them did not know or ...
... benefit more if they sought advice from doctors, pharmacists, study ... person with knee pain who learns that the cause is ... do the right things to treat it, and probably won,t ... , "Most of the things they did were appropriate," said ...
... ... ... -- Those with aching backs might want to look at their home décor to help ... price range, but many don,t take time to consider products that can actually benefit their ...
... ... ... media company for people who want to live well and do good, today announced three ... YouTube), Jill Beraud (Chief Marketing Officer of Pepsi Americas Beverages & President, Joint Ventures) and ...
... ... , ... 30, 2010 -- Tahitian Noni International (TNI) announced that their 2011 International ... of the Seas, one of the most luxurious cruise ships in the world. The announcement ...
... ... brought over 35 years of experience in industrial fabricating to the medical field. Midbrook ... tables, as well as cleaning and decontamination equipment. , ... (Vocus) March 30, 2010 -- Midbrook, the Jackson, ...
Cached Medicine News:Health News:Many Kids Not Fully Informed of Their Role in Cancer Studies 2Health News:Many With Arthritis Find Simple Solutions for Relief 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 3Health News:GOOD Adds Depth to Advisory Board 2Health News:Caribbean Cruise Announced by Tahitian Noni International for 2011 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 3
(Date:3/5/2015)... -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial ... 2015.  , Revenues were $11.8 million in the ... up 11% from $10.6 million in the 2013 fourth quarter. ... 12% from $38.3 million in 2013. , Gross margin ... in the fourth quarter of the prior year. , ...
(Date:3/5/2015)... 5, 2015 Bayer HealthCare announced today that ... Cancer Foundation of the American Society of Clinical Oncology ... technology platform designed to unlock vast quantities of information ... "Bayer is proud to join ASCO and ... Big Data to help people whose lives have been ...
(Date:3/5/2015)...   AMC Health , the leading provider ... the effectiveness and efficiency of healthcare for high-risk ... and Jared Wilstead have joined the ... Client Development, and Wilstead will serve as Vice ... commitment to accelerating the adoption of monitored care ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... 2010 Mederi Therapeutics Inc announced today that it ... and use of Mederi,s second generation of the Stretta ... of gastric reflux disease, commonly known as GERD, and ... disorder, or BCD.  These latest systems include a streamlined ...
... 8, 2010 DURECT Corporation (Nasdaq: DRRX ... CEO, will be presenting at the Credit Suisse 2010 ... Pacific Time. The conference is being held at the ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) ...
Cached Medicine Technology:Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems 2
... TANGO is designed for ... services, donor centers and ... testing and antibody screening. ... host of functions including ...
The ScanGel® automatic readings are done with a high resolution color video camera. Images can be stored and printed....
... Since the early 1990s, the "Reversed" shoulder ... surgeons with great success. More recently, an ... States have begun to champion this prosthesis ... with it. This reversed technology is the ...
... SPEX Fluorolog-3, a spectro-fluorometer ... JOBIN YVON), is a new ... tailored combination of various components. ... customers to freely choose components ...
Medicine Products: